Behrouz Zand, Gynecologic Oncologist at Houston Methodist, shared a post on LinkedIn:
“Exciting data from our Houston Methodist team at SGO2026 presenting on GLP-1 agonists and reduced obesity-associated cancer risk, with a striking signal in endometrial cancer.
Congrats to Arthur Hsu, Aparna Kamat, and Pedro Ramirez on a fantastic rapid-fire oral.”
Other articles on OncoDaily.
